Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Cancer immunology, immunotherapy: CII [Cancer Immunol Immunother] NLMUID: 8605732"" wg kryterium: JN


Tytuł :
Carrying the torch & facing new challenges.
Autorzy :
Dong H; Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, MN, USA. .
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Dec; Vol. 69 (12), pp. 2411-2412.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Variation in neutrophil to lymphocyte ratio (NLR) as predictor of outcomes in metastatic renal cell carcinoma (mRCC) and non-small cell lung cancer (mNSCLC) patients treated with nivolumab.
Autorzy :
Simonaggio A; Medical Oncology Department, Hôpital Européen Georges Pompidou, Paris, France.
Elaidi R; Medical Oncology Department, Hôpital Européen Georges Pompidou, Paris, France.
Fournier L; Department of Radiology, Hôpital Européen Georges Pompidou, Paris, France.
Fabre E; Medical Thoracic Oncology Department, Hopital Européen Georges Pompidou, Paris, France.; U970, Université Paris Descartes Sorbonne Paris-Cité, 75006, Paris, France.
Ferrari V; Department of Medical Oncology, Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France.
Borchiellini D; Department of Medical Oncology, Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France.
Thouvenin J; Department of Medical Oncology, University Hospital of Strasbourg, Strasbourg, France.
Barthelemy P; Department of Medical Oncology, University Hospital of Strasbourg, Strasbourg, France.
Thibault C; Medical Oncology Department, Hôpital Européen Georges Pompidou, Paris, France.
Tartour E; Department of Immunology, Hôpital Européen Georges Pompidou, 75015, Paris, France.; U970, Université Paris Descartes Sorbonne Paris-Cité, 75006, Paris, France.
Oudard S; Medical Oncology Department, Hôpital Européen Georges Pompidou, Paris, France.
Vano YA; Medical Oncology Department, Hôpital Européen Georges Pompidou, Paris, France. .; INSERM, UMR-S 1138, Centre de Recherche des Cordeliers, Team 'Cancer, Immune Control and Escape', University Paris Descartes Sorbonne, 75006, Paris, France. .
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Dec; Vol. 69 (12), pp. 2513-2522. Date of Electronic Publication: 2020 Jun 19.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Current trends in cancer immunotherapy: a literature-mining analysis.
Autorzy :
Pouliliou S; Department of Radiotherapy/Oncology, School of Medicine, Democritus University of Thrace, Alexandroupolis, Greece. .
Nikolaidis C; School of Medicine, Democritus University of Thrace, Alexandroupolis, Greece.
Drosatos G; Institute for Language and Speech Processing, Athena Research Center, Xanthi, Greece.
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Dec; Vol. 69 (12), pp. 2425-2439. Date of Electronic Publication: 2020 Jun 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Functional effects of immune complexes formed between pembrolizumab and patient-generated anti-drug antibodies.
Autorzy :
Hock BD; Haematology Research Group, Christchurch Hospital and Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand. .
McKenzie JL; Haematology Research Group, Christchurch Hospital and Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
Strother M; Mackenzie Cancer Research Group, Departments of Medicine and Pathology and Biomedical Science, University of Otago Christchurch, Christchurch, New Zealand.; Canterbury Regional Cancer and Haematology Service, Christchurch, New Zealand.
Goddard L; Haematology Research Group, Christchurch Hospital and Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
Butt L; Mackenzie Cancer Research Group, Departments of Medicine and Pathology and Biomedical Science, University of Otago Christchurch, Christchurch, New Zealand.
Currie MJ; Mackenzie Cancer Research Group, Departments of Medicine and Pathology and Biomedical Science, University of Otago Christchurch, Christchurch, New Zealand.
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Dec; Vol. 69 (12), pp. 2453-2464. Date of Electronic Publication: 2020 Jun 16.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Induction of systemic immune responses and reversion of immunosuppression in the tumor microenvironment by a therapeutic vaccine for cervical cancer.
Autorzy :
Che Y; Department of Microbiology and Parasitology, College of Basic Medical Science, China Medical University, No.77 Puhe Road, Shenyang North New Area, Shenyang, 110122, China.
Yang Y; Department of Microbiology and Parasitology, College of Basic Medical Science, China Medical University, No.77 Puhe Road, Shenyang North New Area, Shenyang, 110122, China.
Suo J; Department of Microbiology and Parasitology, College of Basic Medical Science, China Medical University, No.77 Puhe Road, Shenyang North New Area, Shenyang, 110122, China.
An Y; School of Public Health, China Medical University, No.77 Puhe Road, Shenyang North New Area, Shenyang, 110122, China.
Wang X; Department of Microbiology and Parasitology, College of Basic Medical Science, China Medical University, No.77 Puhe Road, Shenyang North New Area, Shenyang, 110122, China. .
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Dec; Vol. 69 (12), pp. 2651-2664. Date of Electronic Publication: 2020 Jul 01.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Characterizing caspase-1 involvement during esophageal disease progression.
Autorzy :
Barber G; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.; Department of Surgery, Trinity Translational Medicine Institute, Trinity College and St. James's Hospital Dublin, Dublin 8, Ireland.
Anand A; Department of Internal Medicine, Technical University of Munich, Munich, Germany.
Katarzyna Oficjalska; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.
Phelan JJ; Department of Surgery, Trinity Translational Medicine Institute, Trinity College and St. James's Hospital Dublin, Dublin 8, Ireland.
Heeran AB; Department of Surgery, Trinity Translational Medicine Institute, Trinity College and St. James's Hospital Dublin, Dublin 8, Ireland.
Flis E; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.
Clarke NE; Department of Surgery, Trinity Translational Medicine Institute, Trinity College and St. James's Hospital Dublin, Dublin 8, Ireland.
Watson JA; Royal College of Surgeons in Ireland and Beaumont Hospital, Dublin 9, Ireland.
Strangmann J; Department of Internal Medicine, Technical University of Munich, Munich, Germany.
Flood B; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.
O'Neill H; Department of Surgery, Trinity Translational Medicine Institute, Trinity College and St. James's Hospital Dublin, Dublin 8, Ireland.
O'Toole D; National Oesophageal and Gastric Centre, St. James's Hospital, Dublin 8, Ireland.
MacCarthy F; National Oesophageal and Gastric Centre, St. James's Hospital, Dublin 8, Ireland.
Ravi N; Department of Surgery, Trinity Translational Medicine Institute, Trinity College and St. James's Hospital Dublin, Dublin 8, Ireland.; National Oesophageal and Gastric Centre, St. James's Hospital, Dublin 8, Ireland.
Reynolds JV; Department of Surgery, Trinity Translational Medicine Institute, Trinity College and St. James's Hospital Dublin, Dublin 8, Ireland.; National Oesophageal and Gastric Centre, St. James's Hospital, Dublin 8, Ireland.
Kay EW; Royal College of Surgeons in Ireland and Beaumont Hospital, Dublin 9, Ireland.
Quante M; Department of Internal Medicine, Technical University of Munich, Munich, Germany.
O'Sullivan J; Department of Surgery, Trinity Translational Medicine Institute, Trinity College and St. James's Hospital Dublin, Dublin 8, Ireland. .
Creagh EM; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland. .
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Dec; Vol. 69 (12), pp. 2635-2649. Date of Electronic Publication: 2020 Jul 01.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Increased Th17 activation and gut microbiota diversity are associated with pembrolizumab-triggered tuberculosis.
Autorzy :
Zhang YB; Shanghai Public Health Clinical Center, Key Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Liu SJ; Department of Pulmonary Disease, PLA 905 Hospital, 9585 Humin Road, Shanghai, 200235, China.
Hu ZD; Shanghai Public Health Clinical Center, Key Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Zhou JX; Department of Pulmonary Disease, PLA 905 Hospital, 9585 Humin Road, Shanghai, 200235, China.
Wang YZ; Department of Pulmonary Disease, PLA 905 Hospital, 9585 Humin Road, Shanghai, 200235, China.
Fang B; Department of Pulmonary Disease, PLA 905 Hospital, 9585 Humin Road, Shanghai, 200235, China.
Wong KW; Shanghai Public Health Clinical Center, Key Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University, Shanghai, China. .
Xia F; Department of Pulmonary Disease, PLA 905 Hospital, 9585 Humin Road, Shanghai, 200235, China. .
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Dec; Vol. 69 (12), pp. 2665-2671. Date of Electronic Publication: 2020 Aug 06.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
TIM-3 blockade combined with bispecific antibody MT110 enhances the anti-tumor effect of γδ T cells.
Autorzy :
Guo Q; Department of Biochemistry and Molecular Biology, School of Basic Medicine, Qingdao University, Qingdao, 266021, China.; Clinical Laboratory, Qingdao Central Hospital, The Second Affiliated Hospital of Qingdao University, Qingdao, China.
Zhao P; Clinical Laboratory, Qingdao Central Hospital, The Second Affiliated Hospital of Qingdao University, Qingdao, China.
Zhang Z; Radiotherapy Department, Qingdao Central Hospital, The Second Affiliated Hospital of Qingdao University, Qingdao, China.
Zhang J; Department of Biochemistry and Molecular Biology, School of Basic Medicine, Qingdao University, Qingdao, 266021, China.
Zhang Z; Department of Biochemistry and Molecular Biology, School of Basic Medicine, Qingdao University, Qingdao, 266021, China.
Hua Y; Department of Biochemistry and Molecular Biology, School of Basic Medicine, Qingdao University, Qingdao, 266021, China.
Han B; Institute of Transfusion Medicine, Qingdao Blood Center, Qingdao, 266071, People's Republic of China.
Li N; Department of Biochemistry and Molecular Biology, School of Basic Medicine, Qingdao University, Qingdao, 266021, China.
Zhao X; Clinical Laboratory, Qingdao Central Hospital, The Second Affiliated Hospital of Qingdao University, Qingdao, China.
Hou L; Department of Biochemistry and Molecular Biology, School of Basic Medicine, Qingdao University, Qingdao, 266021, China. .
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Dec; Vol. 69 (12), pp. 2571-2587. Date of Electronic Publication: 2020 Jun 25.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Anti-tumor efficacy of plasmid encoding emm55 in a murine melanoma model.
Autorzy :
Bunch BL; Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Kodumudi KN; Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Scott E; Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Morse J; Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Weber AM; Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Berglund AE; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.; Department of Oncologic Sciences, University of South Florida, Morsani College of Medicine, Tampa, FL, USA.
Pilon-Thomas S; Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA. .; Department of Oncologic Sciences, University of South Florida, Morsani College of Medicine, Tampa, FL, USA. .; Cutaneous Oncology Program, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, SRB-4, Tampa, FL, 33612, USA. .; Center for Immunization and Infection Research in Cancer (CIIRC), H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. .
Markowitz J; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA. .; Department of Oncologic Sciences, University of South Florida, Morsani College of Medicine, Tampa, FL, USA. .; Immunology Program, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, SRB-3, Tampa, FL, 33606, USA. .
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Dec; Vol. 69 (12), pp. 2465-2476. Date of Electronic Publication: 2020 Jun 18.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Dynamics of peripheral T cell clones during PD-1 blockade in non-small cell lung cancer.
Autorzy :
Zhang F; Beijing Advanced Innovation Center for Genomics, School of Life Sciences, BIOPIC, Peking University, Beijing, 100871, China.; Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, 100871, China.
Bai H; State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, China.
Gao R; Beijing Advanced Innovation Center for Genomics, School of Life Sciences, BIOPIC, Peking University, Beijing, 100871, China.; Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, 100871, China.
Fei K; State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, China.
Duan J; State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, China.
Zhang Z; Beijing Advanced Innovation Center for Genomics, School of Life Sciences, BIOPIC, Peking University, Beijing, 100871, China.; Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, 100871, China.
Wang J; State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, China. .
Hu X; Beijing Advanced Innovation Center for Genomics, School of Life Sciences, BIOPIC, Peking University, Beijing, 100871, China. .
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Dec; Vol. 69 (12), pp. 2599-2611. Date of Electronic Publication: 2020 Jun 26.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases.
Autorzy :
Jansen Y; Department of Medical Oncology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090, Brussels, Belgium. .
Kruse V; Department of Medical Oncology, Universitair Ziekenhuis Gent (UZ Gent), Ghent, Belgium.
Corthals J; Laboratory of Molecular and Cellular Therapy and Dendritic Cell-bank, Vrije Universiteit Brussel, Brussels, Belgium.
Schats K; Histogenex NV, Antwerp, Belgium.
van Dam PJ; Histogenex NV, Antwerp, Belgium.
Seremet T; Department of Medical Oncology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090, Brussels, Belgium.
Heirman C; Laboratory of Molecular and Cellular Therapy and Dendritic Cell-bank, Vrije Universiteit Brussel, Brussels, Belgium.
Brochez L; Department of Medical Oncology, Universitair Ziekenhuis Gent (UZ Gent), Ghent, Belgium.
Kockx M; Histogenex NV, Antwerp, Belgium.
Thielemans K; Laboratory of Molecular and Cellular Therapy and Dendritic Cell-bank, Vrije Universiteit Brussel, Brussels, Belgium.
Neyns B; Department of Medical Oncology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090, Brussels, Belgium.
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Dec; Vol. 69 (12), pp. 2589-2598. Date of Electronic Publication: 2020 Jun 26.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Histopathological growth patterns correlate with the immunoscore in colorectal cancer liver metastasis patients after hepatectomy.
Autorzy :
Liang JY; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.
Xi SY; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.; Department of Pathology, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.
Shao Q; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.; Department of Molecular Diagnostics, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.
Yuan YF; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.; Department of Hepatobiliary Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.
Li BK; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.; Department of Hepatobiliary Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.
Zheng Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.; Department of Hepatobiliary Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.
Wang DS; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.
Wu XJ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.; Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Ding PR; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.; Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Chen G; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.; Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Li LR; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.; Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Wang FH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.
Wang ZQ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.
Pan ZZ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.; Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Xu RH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China. .; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China. .
Li YH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China. .; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China. .
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Dec; Vol. 69 (12), pp. 2623-2634. Date of Electronic Publication: 2020 Jun 29.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Prognostic impacts of tumoral expression and serum levels of PD-L1 and CTLA-4 in colorectal cancer patients.
Autorzy :
Omura Y; Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.
Toiyama Y; Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan. .
Okugawa Y; Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan. .; Department of Genomic Medicine, Mie University Hospital, Tsu, Japan. .
Yin C; Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.
Shigemori T; Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.
Kusunoki K; Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.
Kusunoki Y; Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.
Ide S; Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.
Shimura T; Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.
Fujikawa H; Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.
Yasuda H; Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.
Hiro J; Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.
Ohi M; Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.
Kusunoki M; Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Dec; Vol. 69 (12), pp. 2533-2546. Date of Electronic Publication: 2020 Jun 23.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Anlotinib optimizes anti-tumor innate immunity to potentiate the therapeutic effect of PD-1 blockade in lung cancer.
Autorzy :
Yang Y; Department of Integrative Oncology, Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, Tianjin, 300060, China.; Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Li L; Department of Integrative Oncology, Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, Tianjin, 300060, China.; Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Jiang Z; Department of Integrative Oncology, Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, Tianjin, 300060, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Wang B; Department of Integrative Oncology, Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, Tianjin, 300060, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Pan Z; Department of Integrative Oncology, Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, Tianjin, 300060, China. .; Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China. .; Tianjin's Clinical Research Center for Cancer, Tianjin, China. .
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Dec; Vol. 69 (12), pp. 2523-2532. Date of Electronic Publication: 2020 Jun 23.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
A single-valent long-acting human CD47 antagonist enhances antibody directed phagocytic activities.
Autorzy :
Wu F; School of Pharmacy, Shanghai JiaoTong University, Shanghai, People's Republic of China.
Qiu Y; School of Pharmacy, Shanghai JiaoTong University, Shanghai, People's Republic of China.
Xu Y; School of Pharmacy, Shanghai JiaoTong University, Shanghai, People's Republic of China. .; School of Pharmacy and Chemistry, Dali University, Dali, YunNan, People's Republic of China. .
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Dec; Vol. 69 (12), pp. 2561-2569. Date of Electronic Publication: 2020 Jun 24.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer.
Autorzy :
Komura N; Departments of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Mabuchi S; Departments of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan. .; Department of Obstetrics and Gynecology, Nara Medical University, Kashihara, Nara, 634-8522, Japan. .
Shimura K; Departments of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Yokoi E; Departments of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Kozasa K; Departments of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Kuroda H; Departments of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Takahashi R; Departments of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Sasano T; Departments of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Kawano M; Departments of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Matsumoto Y; Departments of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Kodama M; Departments of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Hashimoto K; Departments of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Sawada K; Departments of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Kimura T; Departments of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Dec; Vol. 69 (12), pp. 2477-2499. Date of Electronic Publication: 2020 Jun 19.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The adjuvant effect of melanin is superior to incomplete Freund's adjuvant in subunit/peptide vaccines in mice.
Autorzy :
Cuzzubbo S; PARCC, INSERM, UMR-970, Université de Paris, 56 rue Leblanc, 75015, Paris, France. .
Banissi C; Laboratoire de Recherches Biochirurgicales (Fondation Carpentier), Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges Pompidou, 75015, Paris, France.
Rouchon MS; Laboratoire de Recherches Biochirurgicales (Fondation Carpentier), Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges Pompidou, 75015, Paris, France.
Tran T; PARCC, INSERM, UMR-970, Université de Paris, 56 rue Leblanc, 75015, Paris, France.
Tanchot C; PARCC, INSERM, UMR-970, Université de Paris, 56 rue Leblanc, 75015, Paris, France.
Tartour E; PARCC, INSERM, UMR-970, Université de Paris, 56 rue Leblanc, 75015, Paris, France.; Service d'Immunologie Biologique, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges Pompidou, 75015, Paris, France.
Carpentier AF; PARCC, INSERM, UMR-970, Université de Paris, 56 rue Leblanc, 75015, Paris, France.; Laboratoire de Recherches Biochirurgicales (Fondation Carpentier), Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges Pompidou, 75015, Paris, France.; Service de Neurologie, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Louis, 75010, Paris, France.
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Dec; Vol. 69 (12), pp. 2501-2512. Date of Electronic Publication: 2020 Jun 19.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Factors associated with ocular adverse event after immune checkpoint inhibitor treatment.
Autorzy :
Kim YJ; Department of Ophthalmology, Institute of Vision Research, Severance Hospital, Yonsei University College of Medicine, Yonsei-ro 50-1, Seodaemun-gu, Seoul, Republic of Korea.
Lee JS; Department of Ophthalmology, Institute of Vision Research, Severance Hospital, Yonsei University College of Medicine, Yonsei-ro 50-1, Seodaemun-gu, Seoul, Republic of Korea.
Lee J; Department of Ophthalmology, Institute of Vision Research, Severance Hospital, Yonsei University College of Medicine, Yonsei-ro 50-1, Seodaemun-gu, Seoul, Republic of Korea.
Lee SC; Department of Ophthalmology, Konyang University College of Medicine, Daejeon, Republic of Korea.
Kim TI; Department of Ophthalmology, Institute of Vision Research, Severance Hospital, Yonsei University College of Medicine, Yonsei-ro 50-1, Seodaemun-gu, Seoul, Republic of Korea.
Byeon SH; Department of Ophthalmology, Institute of Vision Research, Severance Hospital, Yonsei University College of Medicine, Yonsei-ro 50-1, Seodaemun-gu, Seoul, Republic of Korea.
Lee CS; Department of Ophthalmology, Institute of Vision Research, Severance Hospital, Yonsei University College of Medicine, Yonsei-ro 50-1, Seodaemun-gu, Seoul, Republic of Korea. .
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Dec; Vol. 69 (12), pp. 2441-2452. Date of Electronic Publication: 2020 Jun 17.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Multi-antigen DNA vaccine delivered by polyethylenimine and Salmonella enterica in neuroblastoma mouse model.
Autorzy :
Stegantseva MV; Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, v. Borovlyani, Minsk, 220053, Belarus. .
Shinkevich VA; Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, v. Borovlyani, Minsk, 220053, Belarus.
Tumar EM; Institute of Bioorganic Chemistry, National Academy of Sciences of Belarus, Minsk, 220141, Belarus.
Meleshko AN; Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, v. Borovlyani, Minsk, 220053, Belarus.
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Dec; Vol. 69 (12), pp. 2613-2622. Date of Electronic Publication: 2020 Jun 27.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Pretreatment body mass index and clinical outcomes in cancer patients following immune checkpoint inhibitors: a systematic review and meta-analysis.
Autorzy :
Chen H; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Beijing Key Laboratory of Clinical Study On Anticancer Molecular Targeted Drugs, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Wang D; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Zhong Q; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Beijing Key Laboratory of Clinical Study On Anticancer Molecular Targeted Drugs, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Tao Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Beijing Key Laboratory of Clinical Study On Anticancer Molecular Targeted Drugs, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Zhou Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Beijing Key Laboratory of Clinical Study On Anticancer Molecular Targeted Drugs, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Shi Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Beijing Key Laboratory of Clinical Study On Anticancer Molecular Targeted Drugs, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China. .
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Dec; Vol. 69 (12), pp. 2413-2424. Date of Electronic Publication: 2020 Aug 04.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies